From: Can the vector space model be used to identify biological entity activities?
Subnetwork | Dimensional Space | New Interaction | Level of Interaction |
---|---|---|---|
6 | gene target | androgen receptor adrenaline | 0.9757 |
2 | disease gene | HIV transforming growth factor, beta 1 | 0.9738 |
5 | drug target | verapamil cyclooxygenase 2 | 0.9597 |
1 | disease drug | erectile dysfunction divalproex | 0.9470 |
3 | disease target | arrhythmia cyclic-gmp phosphodiesterase | 0.9272 |
4 | drug gene | ciclosporin androgen receptor | 0.8211 |
8 | disease drug target | alzheimer dementia acetylsalicylic acid adrenaline | 0.8807 |
10 | drug gene target | acarbose apolipoprotein a 1 lymphotoxin | 0.8723 |
9 | disease gene target | parkinson disease apolipoprotein e choline acetylase | 0.8695 |
7 | disease drug gene | gout hydrochlorothiazide endothelin 1 | 0.8357 |
11 | disease drug gene target | breast adenocarcinoma tamoxifen ppar-gamma hmg-coa reductase | 0.7826 |